Literature DB >> 7094016

Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas.

L C Padhy, C Shih, D Cowing, R Finkelstein, R A Weinberg.   

Abstract

DNAs from nitrosoethylurea-induced rat neuroblastomas transform NIH/3T3 mouse fibroblasts in a transfection assay. DNAs of such transformed cells can be used in a subsequent cycle of transfection to generate secondary foci that contain virtually no foreign genetic material besides the sequences carrying the rat neuroblastoma transforming function. These secondary neuroblastoma transfectants were injected into young mice and grew out into fibrosarcomas. Sera from these mice were examined for reactivity with any proteins which were induced specifically by the neuroblastoma transforming sequence. These sera precipitate a polypeptide of about 185,000 daltons from 35S-methionine-labeled cell lysates of the rat neuroblastoma cells that served as DNA donors and in all transfection-derived primary and secondary foci. This protein is present in high levels in all neuroblastoma transfectant clones, but was not detectable in a variety of other transformed cells. Antisera were prepared from mice bearing tumors induced by transformed cells derived by transfection of DNAs from various tumor cell types unrelated to rat neuroblastoma. These antisera failed to immunoprecipitate the 185,000 dalton protein. These data indicate that the synthesis of the 185,000 dalton protein is specifically induced by the neuroblastoma transforming sequence. The protein may be encoded by the transforming sequence and may mediate transformation in this chemically induced tumor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7094016     DOI: 10.1016/0092-8674(82)90065-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  53 in total

1.  Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction.

Authors:  T E Godfrey; S H Kim; M Chavira; D W Ruff; R S Warren; J W Gray; R H Jensen
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

Review 2.  Integrating trastuzumab in the treatment of breast cancer. Current status and future trends.

Authors:  Alberto Ocaña; César A Rodríguez; Juan J Cruz
Journal:  Clin Transl Oncol       Date:  2005-04       Impact factor: 3.405

3.  Identification and characterization of a novel enhancer for the rat neu promoter.

Authors:  D H Yan; M C Hung
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

4.  Specific activation of the cellular Harvey-ras oncogene in dimethylbenzanthracene-induced mouse mammary tumors.

Authors:  S Dandekar; S Sukumar; H Zarbl; L J Young; R D Cardiff
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

5.  Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function.

Authors:  P W Brandt-Rauf; S Rackovsky; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles.

Authors:  M C Hung; A L Schechter; P Y Chevray; D F Stern; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

7.  Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.

Authors:  Heidi Greulich; Bethany Kaplan; Philipp Mertins; Tzu-Hsiu Chen; Kumiko E Tanaka; Cai-Hong Yun; Xiaohong Zhang; Se-Hoon Lee; Jeonghee Cho; Lauren Ambrogio; Rachel Liao; Marcin Imielinski; Shantanu Banerji; Alice H Berger; Michael S Lawrence; Jinghui Zhang; Nam H Pho; Sarah R Walker; Wendy Winckler; Gad Getz; David Frank; William C Hahn; Michael J Eck; D R Mani; Jacob D Jaffe; Steven A Carr; Kwok-Kin Wong; Matthew Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

8.  Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein.

Authors:  P W Brandt-Rauf; M R Pincus; J M Chen
Journal:  J Protein Chem       Date:  1989-12

9.  Analysis of c-erbB2 protein content of human glioma cells and tumor tissue.

Authors:  H H Engelhard; M Wolters; P S Criswell
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Adaptive Immune Responses and HER2/neu Positive Breast Cancer.

Authors:  Eric D Mortenson; Yang-Xin Fu
Journal:  Curr Pathobiol Rep       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.